You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Aminoglutethimide treatment for metastatic breast cancer can cause severe hyperkalemia, a rare complication. Regular monitoring or prophylactic mineralocorticoid replacement is crucial for patient safety during therapy.
Area of Science:
Background:
Observation:
Findings:
Implications: